GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » YoY Rev. per Sh. Growth

Noile-Immune Biotech (TSE:4893) YoY Rev. per Sh. Growth : -67.57% (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Noile-Immune Biotech's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2024 was -67.57%.

Noile-Immune Biotech's Revenue per Share for the three months ended in Mar. 2024 was 円0.06.

Noile-Immune Biotech YoY Rev. per Sh. Growth Historical Data

The historical data trend for Noile-Immune Biotech's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noile-Immune Biotech YoY Rev. per Sh. Growth Chart

Noile-Immune Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23
YoY Rev. per Sh. Growth
- 10.46 552.12 -52.18

Noile-Immune Biotech Quarterly Data
Dec20 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only - - - -49.59 -67.57

Noile-Immune Biotech YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Noile-Immune Biotech's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2023 )
=(Revenue per Share (A: Dec. 2023 )-Revenue per Share (A: Dec. 2022 ))/ | Revenue per Share (A: Dec. 2022 ) |
=(7.64-15.977)/ | 15.977 |
=-52.18 %

Noile-Immune Biotech's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Mar. 2024 )
=(Revenue per Share (Q: Mar. 2024 )-Revenue per Share (Q: Mar. 2023 )) / | Revenue per Share (Q: Mar. 2023 )) |
=(0.06-0.185)/ | 0.185 |
=-67.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Noile-Immune Biotech YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Noile-Immune Biotech's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Noile-Immune Biotech (TSE:4893) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
TSE:4575 TSE:4563 TSE:4978 TSE:4579 TSE:7774 TSE:2183 TSE:7096 TSE:4894 TSE:4571 TSE:4593 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012
Website
https://www.noile-immune.com
Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.

Noile-Immune Biotech (TSE:4893) Headlines

No Headlines